Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Virology|March 3, 2007
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and DPeter Abbink, Angelique A C Lemckert, Bonnie A Ewald, et al.Journal of Clinical Microbiology|October 6, 2006
Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan AfricaAnna R Thorner, Ronald Vogels, Jorn Kaspers, et al.Journal of Virology|July 15, 2003
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunityRonald Vogels, David Zuijdgeest, Richard van Rijnsoever, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2005
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinShawn M Sumida, Diana M Truitt, Angelique A C Lemckert, et al.Science (New York, N.Y.)|July 9, 2011
A highly conserved neutralizing epitope on group 2 influenza A virusesDamian C Ekiert, Robert H E Friesen, Gira Bhabha, et al.Nature Communications|November 14, 2024
A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and naïve non-human primatesAneesh Vijayan, Ronald Vogels, Rachel Groppo, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2013
A common solution to group 2 influenza virus neutralizationRobert H E Friesen, Peter S Lee, Esther J M Stoop, et al.NPJ Vaccines|October 21, 2020
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responsesRinke Bos, Lucy Rutten, Joan E M van der Lubbe, et al.Science (New York, N.Y.)|August 11, 2012
Highly conserved protective epitopes on influenza B virusesCyrille Dreyfus, Nick S Laursen, Ted Kwaks, et al.Science (New York, N.Y.)|November 3, 2018
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutininNick S Laursen, Robert H E Friesen, Xueyong Zhu, et al.Pageof 4